Welcome back,

CONFERENCE UPDATE

EHA 2025

The European Hematology Association (EHA) 2025 Congress

June 12-15, 2025 |

Milan, Italy

2025

Gilteritinib continues to improve OS in R/R FLT3-mutated AML at 3-year follow-up of the Asian-centric phase 3 COMMODORE trial
HEMATOLOGY

19 Sep 2025
Prognostic insights into SMF from the new molecularly enhanced MYSEC-PM
HEMATOLOGY

4 Sep 2025
Personalized decision-support system refines timing of allogeneic-HSCT in CMML
HEMATOLOGY

4 Sep 2025
Sustained efficacy of fixed-duration ibrutinib + venetoclax in CLL/SLL: Final analysis of the phase 2 CAPTIVATE study
HEMATOLOGY

9 Aug 2025

eaa0190a-4510-467f-900f-c94c7b668484